Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP

Journal of Headache and Pain

Volumn 11, Issue 4, 2010, Pages 309-316

  Schytz, Henrik Winther ^a   Holst, Helle ^b   Arendt Nielsen, Lars ^b   Olesen, Jes ^a   Ashina, Messoud ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

Cutaneous pain model; Mast cell degranulation; Migraine without aura; Neurogenic inflammation; PACAP38; Pain; VIP

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUTE DISEASE; ADULT; ARTICLE; BIOLOGICAL MODEL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; METABOLISM; MIDDLE AGED; NEUROGENIC INFLAMMATION; NOCICEPTIVE RECEPTOR; PAIN; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, NEUROLOGICAL; NEUROGENIC INFLAMMATION; NOCICEPTORS; PAIN; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; VASOACTIVE INTESTINAL PEPTIDE; YOUNG ADULT;

EID: 79953054042     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-010-0214-3     Document Type: Article

References (52)

1. Dickinson T, Fleetwood-Walker SM (1999) VIP and PACAP: very important in pain? Trends Pharmacol Sci 20:324-329 (Pubitemid 29368372)
2. Dickson L, Aramori I, Sharkey J, Finlayson K (2006) VIP and PACAP receptor pharmacology: a comparison of intracellular signaling pathways. Ann N Y Acad Sci 1070:239-242 (Pubitemid 44126649)
3. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C (1991) Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 129:2787-2789
4. Ghatei MA, Takahashi K, Suzuki Y, Gardiner J, Jones PM, Bloom SR (1993) Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. J Endocrinol 136:159-166 (Pubitemid 23016124)
5. Hannibal J, Mikkelsen JD, Clausen H, Holst JJ, Wulff BS, Fahrenkrug J (1995) Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul Pept 55:133-148
6. Mikkelsen JD, Hannibal J, Fahrenkrug J, Larsen PJ, Olcese J, McArdle C (1995) Pituitary adenylate cyclase activating peptide-38 (PACAP-38), PACAP-27, and PACAP related peptide (PRP) in the rat median eminence and pituitary. J Neuroendocrinol 7:47-55
7. Hansen JM, Sitarz J, Birk S, Rahmann AM, Oturai PS, Fahrenkrug J et al (2006) Vasoactive intestinal polypeptide evokes only a minimal headache in healthy volunteers. Cephalalgia 26:992-1003 (Pubitemid 44079724)
8. Rahmann A, Wienecke T, Hansen JM, Fahrenkrug J, Olesen J, Ashina M (2008) Vasoactive intestinal peptide causes marked cephalic vasodilation, but does not induce migraine. Cephalalgia 28:226-236 (Pubitemid 351172031)
9. Schytz HW, Birk S, Wienecke T, Kruuse C, Olesen J, Ashina M (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132:16-25
10. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M (2006) Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 86:1309-1379 (Pubitemid 44523706)
11. Strassman AM, Levy D (2006) Response properties of dural nociceptors in relation to headache. J Neurophysiol 95:1298-1306
12. Schmelz M, Michael K, Weidner C, Schmidt R, Torebjork HE, Handwerker HO (2000) Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport 11:645-648 (Pubitemid 30120491)
13. Anand P, Bloom SR, McGregor GP (1983) Topical capsaicin pretreatment inhibits axon reflex vasodilatation caused by somatostatin and vasoactive intestinal polypeptide in human skin. Br J Pharmacol 78:665-669 (Pubitemid 13111264)
14. Raud J, Dahlen SE, Smedegard G, Hedqvist P (1989) An intravital microscopic model for mast cell-dependent inflammation in the hamster cheek pouch. Acta Physiol Scand 135:95-105 (Pubitemid 19058570)
15. Gazerani P, Andersen OK, Arendt-Nielsen L (2005) A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain 118:155-163 (Pubitemid 41566594)
16. Fullerton A, Fischer T, Lahti A, Wilhelm KP, Takiwaki H, Serup J (1996) Guidelines for measurement of skin colour and erythema. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 35:1-10
17. Drewes AM, Helweg-Larsen S, Petersen P, Brennum J, Andreasen A, Poulsen LH, Jensen TS (1993) McGill Pain Questionnaire translated into Danish: experimental and clinical findings. Clin J Pain 9:80-87 (Pubitemid 23198859)
18. Van der Schueren BJ, de Hoon JN, Vanmolkot FH, Van Hecken A, Depre M, Kane SA et al (2007) Reproducibility of the capsaicin-induced dermal blood flow response as assessed by laser Doppler perfusion imaging. Br J Clin Pharmacol 64:580-590 (Pubitemid 47568811)
19. Dalsgaard CJ, Rydh M, Haegerstrand A (1989) Cutaneous innervation in man visualized with protein gene product 9.5 (PGP 9.5) antibodies. Histochemistry 92:385-390
20. Schulze E, Witt M, Fink T, Hofer A, Funk RH (1997) Immunohistochemical detection of human skin nerve fibers. Acta Histochem 99:301-309 (Pubitemid 27396047)
21. Savage MV, Brengelmann GL, Buchan AM, Freund PR (1990) Cystic fibrosis, vasoactive intestinal polypeptide, and active cutaneous vasodilation. J Appl Physiol 69:2149-2154
22. Groneberg DA, Welker P, Fischer TC, Dinh QT, Grutzkau A, Peiser C et al (2003) Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J Allergy Clin Immunol 111:1099-1105 (Pubitemid 36570872)
23. Steinhoff M, McGregor GP, Radleff-Schlimme A, Steinhoff A, Jarry H, Schmidt WE (1999) Identification of pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP type 1 receptor in human skin: expression of PACAP-38 is increased in patients with psoriasis. Regul Pept 80:49-55 (Pubitemid 29150342)
24. Odum L, Petersen LJ, Skov PS, Ebskov LB (1998) Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells. Inflamm Res 47:488-492 (Pubitemid 29015638)
25. Lundeberg L, Nordlind K (1999) Vasoactive intestinal polypeptide in allergic contact dermatitis: an immunohistochemical and radioimmunoassay study. Arch Dermatol Res 291:201-206 (Pubitemid 29191827)
26. Fischer TC, Dinh QT, Peiser C, Loser C, Fischer A, Groneberg DA (2002) Simultaneous detection of receptor mRNA and ligand protein in human skin tissues. J Cutan Pathol 29:65-71 (Pubitemid 34275800)
27. Rukwied R, Heyer G (1999) Administration of acetylcholine and vasoactive intestinal polypeptide to atopic eczema patients. Exp Dermatol 8:39-45 (Pubitemid 29038041)
28. Jensen K, Tuxen C, Pedersen-Bjergaard U, Jansen I, Edvinsson L, Olesen J (1990) Pain, wheal and flare in human forearm skin induced by bradykinin and 5-hydroxytryptamine. Peptides 11:1133-1138
29. Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J (1989) Algesia and local responses induced by neurokinin A and substance P in human skin and temporal muscle. Peptides 10:1147-1152 (Pubitemid 20037261)
30. Pedersen-Bjergaard U, Nielsen LB, Jensen K, Edvinsson L, Jansen I, Olesen J (1991) Calcitonin gene-related peptide, neurokinin A and substance P: effects on nociception and neurogenic inflammation in human skin and temporal muscle. Peptides 12:333-337
31. Huttunen M, Harvima IT, Ackermann L, Harvima RJ, Naukkarinen A, Horsmanheimo M (1996) Neuropeptide- and capsaicin-induced histamine release in skin monitored with the microdialysis technique. Acta Derm Venereol 76:205-209 (Pubitemid 26186300)
32. Brain SD, Tippins JR, Morris HR, MacIntyre I, Williams TJ (1986) Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol 87:533-536 (Pubitemid 16027131)
33. Fjellner B, Hagermark O (1981) Studies on pruritogenic and histamine-releasing effects of some putative peptide neurotransmitters. Acta Derm Venereol 61:245-250 (Pubitemid 11107483)
34. Sikand P, Shimada SG, Green BG, LaMotte RH (2009) Similar itch and nociceptive sensations evoked by punctate cutaneous application of capsaicin, histamine and cowhage. Pain 144:66-75
35. Warren JB, Cockcroft JR, Larkin SW, Kajekar R, Macrae A, Ghatei MA, Bloom SR (1992) Pituitary adenylate cyclase activating polypeptide is a potent vasodilator in humans. J Cardiovasc Pharmacol 20:83-87
36. Hovell CJ, Beasley CR, Mani R, Holgate ST (1987) Laser Doppler flowmetry for determining changes in cutaneous blood flow following intradermal injection of histamine. Clin Allergy 17:469-479 (Pubitemid 17132801)
37. Seebeck J, Kruse ML, Schmidt-Choudry A, Schmidt WE (1998) Pituitary adenylate cyclase activating polypeptide induces degranulation of rat peritoneal mast cells via high-affinity PACAP receptor-independent activation of G proteins. Ann N Y Acad Sci 865:141-146 (Pubitemid 29047821)
38. Burstein R, Yamamura H, Malick A, Strassman AM (1998) Chemical stimulation of the intracranial dura induces enhanced responses to facial stimulation in brain stem trigeminal neurons. J Neurophysiol 79:964-982 (Pubitemid 28095912)
39. Strassman AM, Raymond SA, Burstein R (1996) Sensitization of meningeal sensory neurons and the origin of headaches. Nature 384:560-564 (Pubitemid 26415932)
40. Gazerani P, Andersen OK, Arendt-Nielsen L (2007) Site-specific, dose-dependent, and sex-related responses to the experimental pain model induced by intradermal injection of capsaicin to the foreheads and forearms of healthy humans. J Orofac Pain 21:289-302
41. Moskowitz MA (1993) Neurogenic inflammation in the pathophysiology and treatment of migraine. Neurology 43:S16-S20
42. Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM (2007) Mast cell degranulation activates a pain pathway underlying migraine headache. Pain 130:166-176 (Pubitemid 46843463)
43. Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH (2000) An association between migraine and cutaneous allodynia. Ann Neurol 47:614-624 (Pubitemid 30261897)
44. Wienecke T, Olesen J, Oturai PS, Ashina M (2009) Prostaglandin E2(PGE2) induces headache in healthy subjects. Cephalalgia 29:509-519
45. Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54-61
46. Lassen LH, Thomsen LL, Olesen J (1995) Histamine induces migraine via the H1-receptor. Support for the NO hypothesis of migraine. Neuroreport 6:1475-1479
47. Wienecke T, Olesen J, Oturai PS, Ashina M (2008) Prostacyclin (epoprostenol) induces headache in healthy subjects. Pain 139:106-116
48. Schytz HW, Wienecke T, Olesen J, Ashina M (2009) Carbachol induces headache, but not migraine-like attacks, in migraine without aura patients. Cephalalgia (In press)
49. 2 (Epoprostenol) triggers migraine-like attacks in migraineurs. Cephalalgia (In Press)
50. Levy D (2009) Migraine pain, meningeal inflammation, and mast cells. Curr Pain Headache Rep 13:237-240
51. Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A (2005) The role of mast cells in migraine pathophysiology. Brain Res Brain Res Rev 49:65-76 (Pubitemid 40800163)
52. Ottosson A, Edvinsson L (1997) Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide. Cephalalgia 17:166-174 (Pubitemid 27257341)